TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Revenue

TSH Biopharm Corporation had revenue of 287.12M TWD in the quarter ending March 31, 2025, with 43.21% growth. This brings the company's revenue in the last twelve months to 1.20B, up 38.75% year-over-year. In the year 2024, TSH Biopharm Corporation had annual revenue of 1.12B with 37.59% growth.

• Revenue (ttm): 1.20B
• Revenue Growth: +38.75%
• P/S Ratio: 1.61
• Revenue / Employee: 15.82M
• Employees: 76
• Market Cap: 1.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.12B	304.80M	37.59%
Dec 31, 2023	810.92M	69.85M	9.43%
Dec 31, 2022	741.07M	327.58M	79.23%
Dec 31, 2021	413.48M	-34.38M	-7.68%
Dec 31, 2020	447.86M	-59.80M	-11.78%